JPRN-UMIN000034599招募中未知
Efficacy of alogliptin/metformin combination tablets(INISYNC combination tablets) in type 2 diabetic patients. - Efficacy of alogliptin/metformin combination tablets(INISYNC combination tablets) in type 2 diabetic patients.
Minami Osaka hospital0 个研究点目标入组 120 人开始时间: 2018年10月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with a history of lactic acidosis. 2)Patients with moderate or severe renal dysfunction(eGFR<45mL/min/1.73m2). 3)Patients with severe liver dysfunction such as active hepatitis and liver cirrhosis. 4)Patients with heart failure and acute myocardial infarction, pulmonary embolism such as advanced disability cardiovascular system and lung function. 5)Patients with excessive alcohol intake. 6)Patients with severe infections, before and after surgery, serious trauma. 7)Patient with malignant disease. 8)Pregnant women or patients who may be pregnant.
研究者
相似试验
已完成
4 期
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOSPolycystic Ovary SyndromeInsulin ResistanceNCT02683226University Medical Centre Ljubljana30
已完成
不适用
Comparison of once-daily alogliptin/metformin combination tablets and twice-daily anagliptin/metformin combination tablets switching from twice-daily metformin in Japanese type 2 diabetic patientsType 2 diabetesJPRN-UMIN000034951Fujisawa City Hospital48
招募中
不适用
Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial.Type 2 diabetesJPRN-UMIN000031445ational Hospital Organization Kyoto Medical Center20
进行中（未招募）
不适用
Safety of Anagliptin and MEtformin combination tablets evaluated by non-inferiority between pre- and post-serum Lactate levels In Japanese patients Of type 2 diabetes and moderate renal impairmentJPRN-jRCTs031200366Kajio Hiroshi38
已完成
4 期
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyDiabetes Mellitus, Type 2NCT03499704Celltrion Pharm, Inc.133